The role of mental health and self-efficacy in the pain experience of patients with amyotrophic lateral sclerosis

Helen E. Stephens, Erik Lehman, Divisha Raheja, Chengwu Yang, Susan Walsh, Zachary Simmons

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Complex interactions between pain, depression, and anxiety impact quality of life in patients with ALS. Psychological approaches to pain control may be useful. This study explored the role of self-efficacy in mitigating pain. Individuals registered with the Agency for Toxic Substances and Disease Registry National ALS Registry and who experienced pain were invited to participate in an online survey. Subjects completed the Brief Pain Inventory-Short Form, Hospital Anxiety and Depression Scale, and Chronic Pain Self-Efficacy Scale. Correlations between variables were determined. Multiple linear regression models assessed relationships between depression, anxiety and self-efficacy predictions, and pain severity, interference, and relief. Results recorded that there were 197 participants (58% males, mean age 59 ± 10 years). Cases or borderline cases of depression or anxiety were common. Mean levels of pain were moderate. Higher pain self-efficacy scores predicted lower pain severity, lower pain interference, and higher pain relief with treatment. As depression scores increased, pain interference with daily life was higher. In conclusion, anxiety and depression are common in patients with ALS and pain. Self-efficacy appears to mitigate pain. A multifactorial approach to pain management should be considered in these patients, addressing mental health and self-efficacy to augment pharmacologic pain treatments.

Original languageEnglish (US)
Pages (from-to)206-212
Number of pages7
JournalAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume17
Issue number3-4
DOIs
StatePublished - May 18 2016

Fingerprint

Amyotrophic Lateral Sclerosis
Self Efficacy
Mental Health
Pain
Depression
Anxiety
Registries
Linear Models
Poisons
Pain Management
Chronic Pain

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Stephens, Helen E. ; Lehman, Erik ; Raheja, Divisha ; Yang, Chengwu ; Walsh, Susan ; Simmons, Zachary. / The role of mental health and self-efficacy in the pain experience of patients with amyotrophic lateral sclerosis. In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2016 ; Vol. 17, No. 3-4. pp. 206-212.
@article{cdfd0d517da64a0b9f1427bab83f6047,
title = "The role of mental health and self-efficacy in the pain experience of patients with amyotrophic lateral sclerosis",
abstract = "Complex interactions between pain, depression, and anxiety impact quality of life in patients with ALS. Psychological approaches to pain control may be useful. This study explored the role of self-efficacy in mitigating pain. Individuals registered with the Agency for Toxic Substances and Disease Registry National ALS Registry and who experienced pain were invited to participate in an online survey. Subjects completed the Brief Pain Inventory-Short Form, Hospital Anxiety and Depression Scale, and Chronic Pain Self-Efficacy Scale. Correlations between variables were determined. Multiple linear regression models assessed relationships between depression, anxiety and self-efficacy predictions, and pain severity, interference, and relief. Results recorded that there were 197 participants (58{\%} males, mean age 59 ± 10 years). Cases or borderline cases of depression or anxiety were common. Mean levels of pain were moderate. Higher pain self-efficacy scores predicted lower pain severity, lower pain interference, and higher pain relief with treatment. As depression scores increased, pain interference with daily life was higher. In conclusion, anxiety and depression are common in patients with ALS and pain. Self-efficacy appears to mitigate pain. A multifactorial approach to pain management should be considered in these patients, addressing mental health and self-efficacy to augment pharmacologic pain treatments.",
author = "Stephens, {Helen E.} and Erik Lehman and Divisha Raheja and Chengwu Yang and Susan Walsh and Zachary Simmons",
year = "2016",
month = "5",
day = "18",
doi = "10.3109/21678421.2015.1131832",
language = "English (US)",
volume = "17",
pages = "206--212",
journal = "Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration",
issn = "2167-8421",
publisher = "Informa Healthcare",
number = "3-4",

}

The role of mental health and self-efficacy in the pain experience of patients with amyotrophic lateral sclerosis. / Stephens, Helen E.; Lehman, Erik; Raheja, Divisha; Yang, Chengwu; Walsh, Susan; Simmons, Zachary.

In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 17, No. 3-4, 18.05.2016, p. 206-212.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The role of mental health and self-efficacy in the pain experience of patients with amyotrophic lateral sclerosis

AU - Stephens, Helen E.

AU - Lehman, Erik

AU - Raheja, Divisha

AU - Yang, Chengwu

AU - Walsh, Susan

AU - Simmons, Zachary

PY - 2016/5/18

Y1 - 2016/5/18

N2 - Complex interactions between pain, depression, and anxiety impact quality of life in patients with ALS. Psychological approaches to pain control may be useful. This study explored the role of self-efficacy in mitigating pain. Individuals registered with the Agency for Toxic Substances and Disease Registry National ALS Registry and who experienced pain were invited to participate in an online survey. Subjects completed the Brief Pain Inventory-Short Form, Hospital Anxiety and Depression Scale, and Chronic Pain Self-Efficacy Scale. Correlations between variables were determined. Multiple linear regression models assessed relationships between depression, anxiety and self-efficacy predictions, and pain severity, interference, and relief. Results recorded that there were 197 participants (58% males, mean age 59 ± 10 years). Cases or borderline cases of depression or anxiety were common. Mean levels of pain were moderate. Higher pain self-efficacy scores predicted lower pain severity, lower pain interference, and higher pain relief with treatment. As depression scores increased, pain interference with daily life was higher. In conclusion, anxiety and depression are common in patients with ALS and pain. Self-efficacy appears to mitigate pain. A multifactorial approach to pain management should be considered in these patients, addressing mental health and self-efficacy to augment pharmacologic pain treatments.

AB - Complex interactions between pain, depression, and anxiety impact quality of life in patients with ALS. Psychological approaches to pain control may be useful. This study explored the role of self-efficacy in mitigating pain. Individuals registered with the Agency for Toxic Substances and Disease Registry National ALS Registry and who experienced pain were invited to participate in an online survey. Subjects completed the Brief Pain Inventory-Short Form, Hospital Anxiety and Depression Scale, and Chronic Pain Self-Efficacy Scale. Correlations between variables were determined. Multiple linear regression models assessed relationships between depression, anxiety and self-efficacy predictions, and pain severity, interference, and relief. Results recorded that there were 197 participants (58% males, mean age 59 ± 10 years). Cases or borderline cases of depression or anxiety were common. Mean levels of pain were moderate. Higher pain self-efficacy scores predicted lower pain severity, lower pain interference, and higher pain relief with treatment. As depression scores increased, pain interference with daily life was higher. In conclusion, anxiety and depression are common in patients with ALS and pain. Self-efficacy appears to mitigate pain. A multifactorial approach to pain management should be considered in these patients, addressing mental health and self-efficacy to augment pharmacologic pain treatments.

UR - http://www.scopus.com/inward/record.url?scp=84958543657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958543657&partnerID=8YFLogxK

U2 - 10.3109/21678421.2015.1131832

DO - 10.3109/21678421.2015.1131832

M3 - Article

C2 - 26878392

AN - SCOPUS:84958543657

VL - 17

SP - 206

EP - 212

JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

SN - 2167-8421

IS - 3-4

ER -